Engineered T cells: the promise and challenges of cancer immunotherapy
By A. Fesnak, C. June, B. Levine. Nature Reviews. Cancer, 2016
1,002 citations recorded by the source corpus.
Subfields: Genetics, Molecular Biology, Oncology
View Paper: https://www.semanticscholar.org/paper/40266068b37d540aa85811a9a96a3be850c0668c
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- A. Shimabukuro-Vornhagen
- M. V. von Bergwelt-Baildon
- M. Subklewe
- Philipp Gödel
- H. Schlößer
- M. Kochanek
- H. Stemmler
- M. Schlaak
Citations in the corpus
- Cytokine release syndrome (2018, background): “activation of CAR T cells or will include suicide switches that allow controlled depletion of CAR T cells [85, 86].”